556 related articles for article (PubMed ID: 25271795)
21. IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction?
Hvid M; Vestergaard C; Kemp K; Christensen GB; Deleuran B; Deleuran M
J Invest Dermatol; 2011 Jan; 131(1):150-7. PubMed ID: 20861853
[TBL] [Abstract][Full Text] [Related]
22. Human β-defensin-2 as a marker for disease severity and skin barrier properties in atopic dermatitis.
Clausen ML; Jungersted JM; Andersen PS; Slotved HC; Krogfelt KA; Agner T
Br J Dermatol; 2013 Sep; 169(3):587-93. PubMed ID: 23647067
[TBL] [Abstract][Full Text] [Related]
23. Cytokine modulation of atopic dermatitis filaggrin skin expression.
Howell MD; Kim BE; Gao P; Grant AV; Boguniewicz M; Debenedetto A; Schneider L; Beck LA; Barnes KC; Leung DY
J Allergy Clin Immunol; 2007 Jul; 120(1):150-5. PubMed ID: 17512043
[TBL] [Abstract][Full Text] [Related]
24. Clinical severity correlates with impaired barrier in filaggrin-related eczema.
Nemoto-Hasebe I; Akiyama M; Nomura T; Sandilands A; McLean WH; Shimizu H
J Invest Dermatol; 2009 Mar; 129(3):682-9. PubMed ID: 18818676
[TBL] [Abstract][Full Text] [Related]
25. Impaired Toll-like receptor 2-mediated Th1 and Th17/22 cytokines secretion in human peripheral blood mononuclear cells from patients with atopic dermatitis.
Yu Y; Zhang Y; Zhang J; Dou X; Yang H; Shao Y; Wang K; Yu B; Zhang W; Lau HY
J Transl Med; 2015 Dec; 13():384. PubMed ID: 26682905
[TBL] [Abstract][Full Text] [Related]
26. Profile of skin barrier proteins and cytokines in adults with atopic dermatitis.
Orfali RL; Zaniboni MC; Aoki V
G Ital Dermatol Venereol; 2017 Apr; 152(2):140-147. PubMed ID: 27982552
[TBL] [Abstract][Full Text] [Related]
27. Increased Interleukin-19 Expression in Cutaneous T-cell Lymphoma and Atopic Dermatitis.
Oka T; Sugaya M; Takahashi N; Nakajima R; Otobe S; Kabasawa M; Suga H; Miyagaki T; Asano Y; Sato S
Acta Derm Venereol; 2017 Nov; 97(10):1172-1177. PubMed ID: 28597022
[TBL] [Abstract][Full Text] [Related]
28. In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis.
Katagiri K; Arakawa S; Hatano Y
Arch Dermatol Res; 2007 Jan; 298(8):397-401. PubMed ID: 17021766
[TBL] [Abstract][Full Text] [Related]
29. Skin reaction and regeneration after single sodium lauryl sulfate exposure stratified by filaggrin genotype and atopic dermatitis phenotype.
Bandier J; Carlsen BC; Rasmussen MA; Petersen LJ; Johansen JD
Br J Dermatol; 2015 Jun; 172(6):1519-1529. PubMed ID: 25581911
[TBL] [Abstract][Full Text] [Related]
30. Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment.
Yatagai T; Shimauchi T; Yamaguchi H; Sakabe JI; Aoshima M; Ikeya S; Tatsuno K; Fujiyama T; Ito T; Ojima T; Tokura Y
J Dermatol Sci; 2018 Jan; 89(1):33-39. PubMed ID: 29122406
[TBL] [Abstract][Full Text] [Related]
31. Altered mRNA and protein expression of filaggrin in the skin of a canine animal model for atopic dermatitis.
Santoro D; Marsella R; Ahrens K; Graves TK; Bunick D
Vet Dermatol; 2013 Jun; 24(3):329-36, e73. PubMed ID: 23668858
[TBL] [Abstract][Full Text] [Related]
32. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema.
Jungersted JM; Scheer H; Mempel M; Baurecht H; Cifuentes L; Høgh JK; Hellgren LI; Jemec GB; Agner T; Weidinger S
Allergy; 2010 Jul; 65(7):911-8. PubMed ID: 20132155
[TBL] [Abstract][Full Text] [Related]
33. IL-25 induces both inflammation and skin barrier dysfunction in atopic dermatitis.
Deleuran M; Hvid M; Kemp K; Christensen GB; Deleuran B; Vestergaard C
Chem Immunol Allergy; 2012; 96():45-49. PubMed ID: 22433370
[TBL] [Abstract][Full Text] [Related]
34. Does filaggrin expression correlate with severity of clinical signs in dogs with atopic dermatitis?
Marsella R
Vet Dermatol; 2013 Apr; 24(2):266-e59. PubMed ID: 23398596
[TBL] [Abstract][Full Text] [Related]
35. Increased serum levels of interleukin 33 in patients with atopic dermatitis.
Tamagawa-Mineoka R; Okuzawa Y; Masuda K; Katoh N
J Am Acad Dermatol; 2014 May; 70(5):882-8. PubMed ID: 24569114
[TBL] [Abstract][Full Text] [Related]
36. Skin barrier dysfunction and low antimicrobial peptide expression in cutaneous T-cell lymphoma.
Suga H; Sugaya M; Miyagaki T; Ohmatsu H; Kawaguchi M; Takahashi N; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2014 Aug; 20(16):4339-48. PubMed ID: 24919568
[TBL] [Abstract][Full Text] [Related]
37. Antagonistic Effects of IL-4 on IL-17A-Mediated Enhancement of Epidermal Tight Junction Function.
Brewer MG; Yoshida T; Kuo FI; Fridy S; Beck LA; De Benedetto A
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438472
[TBL] [Abstract][Full Text] [Related]
38. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.
Neis MM; Peters B; Dreuw A; Wenzel J; Bieber T; Mauch C; Krieg T; Stanzel S; Heinrich PC; Merk HF; Bosio A; Baron JM; Hermanns HM
J Allergy Clin Immunol; 2006 Oct; 118(4):930-7. PubMed ID: 17030248
[TBL] [Abstract][Full Text] [Related]
39. Increased epidermal filaggrin in chronic idiopathic urticaria is associated with severity of urticaria.
Ye YM; Kim BE; Shin YS; Park HS; Leung DYM
Ann Allergy Asthma Immunol; 2014 Jun; 112(6):533-538. PubMed ID: 24726196
[TBL] [Abstract][Full Text] [Related]
40. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.
Salimi M; Barlow JL; Saunders SP; Xue L; Gutowska-Owsiak D; Wang X; Huang LC; Johnson D; Scanlon ST; McKenzie AN; Fallon PG; Ogg GS
J Exp Med; 2013 Dec; 210(13):2939-50. PubMed ID: 24323357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
